Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Astellas Pharma Inc
Pfizer
Jazz Pharmaceuticals
Actuate Therapeutics Inc.
Brigham and Women's Hospital
Hoffmann-La Roche
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
Memorial Sloan Kettering Cancer Center
Daiichi Sankyo
HealthPartners Institute
Stanford University
Mayo Clinic
Seagen Inc.
Incyte Corporation
University of Washington
City of Hope Medical Center
Bayer
Tempus AI
Brown University
Pfizer
National Cancer Institute (NCI)
British Columbia Cancer Agency
Washington University School of Medicine
University of California, Irvine
Tongji Hospital
Stony Brook University
Elevation Oncology
Optimal Health Research
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Zhejiang Provincial People's Hospital
Exelixis
National Institutes of Health Clinical Center (CC)
Sun Yat-sen University
Erasmus Medical Center
Universitair Ziekenhuis Brussel
Convalife (Shanghai) Co., Ltd.
Stanford University
Fondazione per la Medicina Personalizzata
pharmaand GmbH
Hoffmann-La Roche
OncoNano Medicine, Inc.
Jules Bordet Institute
Second Affiliated Hospital of Soochow University
Ambrx, Inc.
Bayer
Wake Forest University Health Sciences